Good morning, investor! We’re at the halfway point of the week but there’s no slowing down as we dive into the biggest pre-market stock movers for Wednesday!
We’ve got earnings reports, clinical trial results, IPOs and more to talk about today.
Let’s get into that news below!
Pre-Market Stock Movers: 10 Top Gainers
- Galera Therapeutics (NASDAQ:GRTX) stock is soaring more than 18% continue to rally on corrected clinical trial results.
- SeaChange International (NASDAQ:SEAC) shares are rising over 14% with the release of its Q3 fiscal 2022 earnings report.
- Ideal Power (NASDAQ:IPWR) stock is gaining more than 13% despite a lack of news this morning.
- CF Acquisition (NASDAQ:CFVI) shares are increasing about 11% as they recover from an unexpected drop yesterday.
- Mesoblast (NASDAQ:MESO) stock is climbing over 10% as shares regain lost ground from an abandoned Novartis (NYSE:NVS) agreement.
- Biofrontera (NASDAQ:BFRI) shares are heading more than 9% higher after dropping lower late Tuesday.
- Inpixon (NASDAQ:INPX) stock is sitting close to 9% higher as volatility continues on plans to review strategic alternatives.
- East Stone Acquisition (NASDAQ:ESSC) shares are getting an over 8% boost on increased social media chatter.
- Borr Drilling (NYSE:BORR) stock is jumping more than 7% following a reverse stock spilt yesterday.
- Uxin (NASDAQ:UXIN) shares are up over 7% after releasing its fiscal Q2 2022 earnings report.
10 Top Losers
- Sidus Space (NASDAQ:SIDU) stock is diving more than 13% following gains Tuesday on its IPO.
- Alzamend Neuro (NASDAQ:ALZN) shares are slipping over 9% after a rally yesterday from social media talk.
- Idera Pharmaceuticals (NASDAQ:IDRA) stock is taking a more than 9% beating after providing an update on clinical results for one of its treatments.
- I-MAB (NASDAQ:IMAB) shares are falling over 8% after presenting clinical trial data yesterday.
- Legend Biotech (NASDAQ:LEGN) stock is decreasing more than 7% after announcing a proposed public offering.
- MIND Technology (NASDAQ:MIND) shares are pulling back over 7% after rallying yesterday on an agreement with the U.S. Navy.
- BeiGene (NASDAQ:BGNE) stock is declining more than 6% after shares made their public debut in Shangai.
- Livent (NYSE:LTHM) shares are dipping over 6% on no apparent news.
- Direxion Daily FTSE China Bull 3x Shares (NYSEARCA:YINN) are losing more than 6% of their value this morning.
- Adagio Therapeutics (NASDAQ:ADGI) stock closes out our pre-market stock movers down over 6% as it continues a fall from yesterday on news its coronavirus antibody won’t work on Omicron.
Original Post Can be Found Here